Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
Recruiting · NCT04532190 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Calgary
View the official record on ClinicalTrials.gov →Interventions studied
rTMS
What this trial is about
Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if theta burst repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.
Who can take part
Age range
9 Years to 15 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of ADHD
- 9-15 years old
- IQ greater than 80
- English fluency (to enable consent/assent)
- If on medication, must have been on the same type and dosage for at least 3 months.
Exclusion criteria
- Diagnosis of mania, psychosis, or bipolar disorder
- Impediments to TMS or MRI (i.e. metal implants in body)
- Prior electroconvulsive therapy or vagus nerve stimulation
- Diagnosis of Autism Spectrum Disorder.
Where it is running
1 location listed.
- Alberta Children's Hospital - Calgary, Alberta, Canada